The Lower Schuylkill Biotech Campus is where Philadelphia’s ecosystem of discovery will grow into life altering outcomes for all and on June 14, 2022, PIDC issued an RFQ looking for the right partner for this unprecedented cell and gene therapy development opportunity. The developer selection process is designed to identify a partner to help us implement the plan to transform 40 acres of vacant riverfront industrial land in Southwest Philadelphia into a modern biotech manufacturing campus that can support up to 1 million SF and $1+ billion investment and as many as 4,000 quality jobs at full build out.
On December 20, 2022, PIDC issued an RFP to three development firms after receiving their responses in mid-October – Quaker Lane Capital, Gattuso Development Partners/AR Spruce, and Lincoln Property Company. Responses are due back from shortlisted developers by early March 2023. A partner is projected to be selected and a development agreement will be negotiated by the second quarter of 2023.
View more information on the Lower Schuylkill Biotech Campus.